Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes (NCT04496479)
A Phase 2a, Open Label, Dose Escalation Study for Safety, Tolerability, and Efficacy of Hepatocyte Transplantation Into Periduodenal Lymph Nodes Among Subjects With End-Stage Liver Disease
🩺 Plain-English Summary (8th-Grade Level)
This Phase 2a clinical trial is a dose escalation study of the safety, tolerability, and efficacy of hepatocyte transplantation into lymph nodes via endoscopic ultrasound among subjects with end-stage liver disease.
Who can join: Review the eligibility criteria below.
Location: Tufts Medical Center — Boston, Massachusetts
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Tufts Medical Center — Boston, Massachusetts
- Houston Methodist Hospital — Houston, Texas
📞 Contact the Study Coordinator
Phone: (412) 860-3599
Email: fontesp@lygenesis.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in End Stage Liver Disease
- Disparities Among Liver Transplant Patients — Phoenix, Arizona
- Tocotrienol Against the Progression of End Stage Liver Disease — Indianapolis, Indiana
- Adverse Outcomes and Mortality in Liver Transplant — Phoenix, Arizona
- Functional Assessment in Liver Transplantation — Little Rock, Arkansas
Explore by condition: All End Stage Liver Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.